Peloton Interactive Inc. announces the recall of its exercise bikes due to safety hazards that may lead to injuries. About 2.2 million units of the brand’s Model PL01 bikes are affected by the recall.
It was stated on the web page of the U.S. Consumer Product Safety Commission (CPSC) that the issue is the adjustable seat of the bike. It may break while in use and eventually hurt the rider. The inspectors may have overlooked the defect on the said Peloton bike model. They may not have spotted this during the post-assembly phase.
According to CNN Business, the CPSC issued the recall on Thursday, May 11, and warned the users about the risk. The safety commission also told the owners to immediately stop using the bike.
Peloton also issued its own statement and said that the affected PL-01 bikes that cost $1,400 were sold from January 2018 to May 2023. The company stressed that the recall is only for the units that were sold in the United States.
The company is aware of the 35 reports where users indicated incidences of their seat breaking. The CPSC said that 13 users from the 35 reports were injured and mentioned fractured wrist, bruises, and lacerations after falling off the bike. Peloton said it sold 2,160,000 units of the bike as of April 30.
“Our commitment to member safety is unwavering. For Peloton, it was important to proactively engage the CPSC to address this issue and to work swiftly and cooperatively to identify a remedy,” Peloton said of the recall.
Based on the information posted on CPSC’s recall announcement, owners of the said exercise bike may get in touch with Peloton for a free repair. The company is also offering a free repair kit that contains the seat post, which they can personally install. Meanwhile, most of the Peloton bikes were sold at Dick’s Sporting Goods outlets across the country and online via Amazon, Onepeloton.com, and Dicksportinggoods.com.
Photo by: Andrew Valdivia/Unsplash


Oil Prices Slide in 2025 as Oversupply and Geopolitical Risks Shape Market Outlook
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Asian Currencies Trade Flat as Dollar Weakens in Thin New Year Trading
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026
USDA $12 Billion Farm Aid Program Draws Mixed Reactions from Row Crop Farmers
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand
Oil Prices Stabilize at Start of 2026 as OPEC+ Policy and Geopolitical Risks Shape Market Outlook
Singapore GDP Growth Surges in 2025 but Outlook Remains Cautious Amid Global Trade Risks
South Korea Factory Output Misses Forecasts in November Amid Ongoing Economic Uncertainty
Citi Forecasts a Volatile but Ongoing Bull Market for S&P 500 in 2026
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Asian Markets Slip as Precious Metals Cool, Geopolitical Tensions Weigh on Sentiment
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
Forex Markets Hold Steady as Traders Await Fed Minutes Amid Thin Year-End Volumes 



